Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.086 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.051 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |